ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
The first hormone replacement therapy for hypoparathyroidism in China obtains IND approval for Phase III clinical trial
June 04, 2021June 1 is World Hypopara Awareness Day. VISEN Pharmaceuticals, a biotech company focused on developing and commercializing innovative endocrine drugs, announced that it has obtained the investigational new drug (IND) approval from the ... -
HP India, Jubilant Bhartia Foundation introduce virtual helpdesk for Co-WIN registrations
June 01, 2021The virtual helpdesk will provide assistance initially in Hindi, English, Telugu, Tamil and Kannada and will add more regional languages soon. -
CKD-hyperparathyroidism, hyperphosphatemia, hyperkalemia market to grow at 6.9% CAGR by 2030: GlobalData
May 19, 2021Historically, the CKD-HPT, HP, and HK disease space mainly consisted of reformulations of existing drugs and repurposed drugs from other disease markets.
Pharma Sources Insight January 2025
